34030727|t|Oligomerization of Lrrk controls actin severing and alpha-synuclein neurotoxicity in vivo.
34030727|a|BACKGROUND: Mutations in LRRK2 are the most common cause of familial Parkinson's disease and typically cause disease in the context of abnormal aggregation and deposition of alpha-synuclein within affected brain tissue. METHODS: We combine genetic analysis of Lrrk-associated toxicity in a penetrant Drosophila model of wild type human alpha-synuclein neurotoxicity with biochemical analyses and modeling of LRRK2 toxicity in human neurons and transgenic mouse models. RESULTS: We demonstrate that Lrrk and alpha-synuclein interact to promote neuronal degeneration through convergent effects on the actin cytoskeleton and downstream dysregulation of mitochondrial dynamics and function. We find specifically that monomers and dimers of Lrrk efficiently sever actin and promote normal actin dynamics in vivo. Oligomerization of Lrrk, which is promoted by dominant Parkinson's disease-causing mutations, reduces actin severing activity in vitro and promotes excess stabilization of F-actin in vivo. Importantly, a clinically protective Lrrk mutant reduces oligomerization and alpha-synuclein neurotoxicity. CONCLUSIONS: Our findings provide a specific mechanistic link between two key molecules in the pathogenesis of Parkinson's disease, alpha-synuclein and LRRK2, and suggest potential new approaches for therapy development.
34030727	19	23	Lrrk	Gene	42447
34030727	33	38	actin	Gene	40444
34030727	52	67	alpha-synuclein	Gene	6622
34030727	68	81	neurotoxicity	Disease	MESH:D020258
34030727	116	121	LRRK2	Gene	120892
34030727	160	179	Parkinson's disease	Disease	MESH:D010300
34030727	265	280	alpha-synuclein	Gene	6622
34030727	351	355	Lrrk	Gene	42447
34030727	367	375	toxicity	Disease	MESH:D064420
34030727	391	401	Drosophila	Species	7227
34030727	421	426	human	Species	9606
34030727	427	442	alpha-synuclein	Gene	6622
34030727	443	456	neurotoxicity	Disease	MESH:D020258
34030727	499	504	LRRK2	Gene	120892
34030727	505	513	toxicity	Disease	MESH:D064420
34030727	517	522	human	Species	9606
34030727	546	551	mouse	Species	10090
34030727	589	593	Lrrk	Gene	42447
34030727	598	613	alpha-synuclein	Gene	6622
34030727	634	655	neuronal degeneration	Disease	MESH:D009410
34030727	690	695	actin	Gene	40444
34030727	827	831	Lrrk	Gene	42447
34030727	850	855	actin	Gene	40444
34030727	875	880	actin	Gene	40444
34030727	918	922	Lrrk	Gene	42447
34030727	954	973	Parkinson's disease	Disease	MESH:D010300
34030727	1001	1006	actin	Gene	40444
34030727	1125	1129	Lrrk	Gene	42447
34030727	1165	1180	alpha-synuclein	Gene	20617
34030727	1181	1194	neurotoxicity	Disease	MESH:D020258
34030727	1307	1326	Parkinson's disease	Disease	MESH:D010300
34030727	1328	1343	alpha-synuclein	Gene	6622
34030727	1348	1353	LRRK2	Gene	120892
34030727	Association	MESH:D064420	42447
34030727	Association	40444	42447
34030727	Association	MESH:D064420	120892
34030727	Association	20617	42447
34030727	Association	42447	6622
34030727	Association	MESH:D010300	6622
34030727	Association	MESH:D009410	40444
34030727	Association	MESH:D020258	20617
34030727	Association	MESH:D010300	42447
34030727	Association	MESH:D009410	42447
34030727	Association	MESH:D010300	120892
34030727	Association	MESH:D020258	6622
34030727	Association	MESH:D009410	6622
34030727	Association	MESH:D020258	42447
34030727	Association	120892	6622

